Nancy A. Johnson

Array ( [id] => 3875553 [patent_doc_number] => 05804367 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-08 [patent_title] => 'Method for quantifying LBP in body fluids' [patent_app_type] => 1 [patent_app_number] => 8/377391 [patent_app_country] => US [patent_app_date] => 1995-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5261 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/804/05804367.pdf [firstpage_image] =>[orig_patent_app_number] => 377391 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3682805 [patent_doc_number] => 05662899 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions' [patent_app_type] => 1 [patent_app_number] => 8/374629 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5536 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/662/05662899.pdf [firstpage_image] =>[orig_patent_app_number] => 374629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3823880 [patent_doc_number] => 05731189 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-24 [patent_title] => 'Human monoclonal antibodies to human immunodeficiency virus' [patent_app_type] => 1 [patent_app_number] => 8/364007 [patent_app_country] => US [patent_app_date] => 1994-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 10591 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/731/05731189.pdf [firstpage_image] =>[orig_patent_app_number] => 364007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3848583 [patent_doc_number] => 05766946 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Monoclonal antibodies to glycoprotein P' [patent_app_type] => 1 [patent_app_number] => 8/356272 [patent_app_country] => US [patent_app_date] => 1994-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4258 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766946.pdf [firstpage_image] =>[orig_patent_app_number] => 356272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234356 [patent_doc_number] => 06117836 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-12 [patent_title] => 'Glycosylation-mediated inhibition of factor X' [patent_app_type] => 1 [patent_app_number] => 8/307609 [patent_app_country] => US [patent_app_date] => 1994-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5142 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/117/06117836.pdf [firstpage_image] =>[orig_patent_app_number] => 307609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3655440 [patent_doc_number] => 05622842 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-04-22 [patent_title] => 'DNA encoding canine immunoglobulin A' [patent_app_type] => 1 [patent_app_number] => 8/336891 [patent_app_country] => US [patent_app_date] => 1994-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7111 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/622/05622842.pdf [firstpage_image] =>[orig_patent_app_number] => 336891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725100 [patent_doc_number] => 05672686 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Bcl-Y - specific antibodies' [patent_app_type] => 1 [patent_app_number] => 8/321071 [patent_app_country] => US [patent_app_date] => 1994-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 17 [patent_no_of_words] => 24323 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672686.pdf [firstpage_image] =>[orig_patent_app_number] => 321071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771916 [patent_doc_number] => 05734022 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Antibodies to a novel mammalian protein associated with uncontrolled cell division' [patent_app_type] => 1 [patent_app_number] => 8/314503 [patent_app_country] => US [patent_app_date] => 1994-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 30 [patent_no_of_words] => 24729 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/734/05734022.pdf [firstpage_image] =>[orig_patent_app_number] => 314503 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876353 [patent_doc_number] => 05728579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-17 [patent_title] => 'DNA encoding Mat-8' [patent_app_type] => 1 [patent_app_number] => 8/289247 [patent_app_country] => US [patent_app_date] => 1994-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 11455 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/728/05728579.pdf [firstpage_image] =>[orig_patent_app_number] => 289247 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3657038 [patent_doc_number] => 05648076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Inhibition of vascular stenosis' [patent_app_type] => 1 [patent_app_number] => 8/281132 [patent_app_country] => US [patent_app_date] => 1994-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4053 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648076.pdf [firstpage_image] =>[orig_patent_app_number] => 281132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4064556 [patent_doc_number] => 05866570 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Treatment of vascular leakage and related syndrome such as septic shock by administration of metalloproteinase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/262888 [patent_app_country] => US [patent_app_date] => 1994-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 21 [patent_no_of_words] => 24772 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866570.pdf [firstpage_image] =>[orig_patent_app_number] => 262888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3623129 [patent_doc_number] => 05688918 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'p53as protein and antibody therefor' [patent_app_type] => 1 [patent_app_number] => 8/259612 [patent_app_country] => US [patent_app_date] => 1994-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 21 [patent_no_of_words] => 7992 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688918.pdf [firstpage_image] =>[orig_patent_app_number] => 259612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3619532 [patent_doc_number] => 05688681 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Monoclonal antibodies to human leukemia inhibitory factor' [patent_app_type] => 1 [patent_app_number] => 8/258918 [patent_app_country] => US [patent_app_date] => 1994-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 13 [patent_no_of_words] => 6530 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/688/05688681.pdf [firstpage_image] =>[orig_patent_app_number] => 258918 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3870912 [patent_doc_number] => 05837810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Polypeptides of lipopolysaccharide binding protein' [patent_app_type] => 1 [patent_app_number] => 8/215089 [patent_app_country] => US [patent_app_date] => 1994-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 9924 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837810.pdf [firstpage_image] =>[orig_patent_app_number] => 215089 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3988983 [patent_doc_number] => 05919452 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-06 [patent_title] => 'Methods of treating TNF.alpha.-mediated disease using chimeric anti-TNF antibodies' [patent_app_type] => 1 [patent_app_number] => 8/192861 [patent_app_country] => US [patent_app_date] => 1994-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 48 [patent_no_of_words] => 49233 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/919/05919452.pdf [firstpage_image] =>[orig_patent_app_number] => 192861 [rel_patent_id] =>[rel_patent_doc_number] =>)